Company Filing History:
Years Active: 2024
Title: Carleton Proctor Goold: Innovator in Selective Protein Degradation
Introduction
Carleton Proctor Goold is a notable inventor based in Brighton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of protein degradation. His innovative work has led to the development of a unique patent that addresses important challenges in protein manipulation.
Latest Patents
Goold holds a patent for "Compositions and methods for selective protein degradation." This invention provides compositions that include a fusion polypeptide and methods for creating a fusion polypeptide. The fusion polypeptide consists of a COF1/CRBN-binding polypeptide, COF2/CRBN-binding polypeptide, or COF3/CRBN-binding polypeptide, along with a heterologous polypeptide of interest. This advancement has the potential to impact various applications in research and medicine.
Career Highlights
Carleton Goold is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to further his research and development efforts in the field of biotechnology. Goold's expertise and innovative mindset have positioned him as a valuable asset in his field.
Collaborations
Throughout his career, Goold has collaborated with esteemed colleagues, including James Bradner and Andrei Alexandrovich Golosov. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared research goals.
Conclusion
Carleton Proctor Goold is a distinguished inventor whose work in selective protein degradation has made a significant impact in biotechnology. His contributions, particularly through his patent and collaborations, highlight the importance of innovation in addressing complex scientific challenges.